The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10028959 B1

PDF
Full Text
Expired
Date of Patent:
Jul. 24, 2018

Filed:

Mar. 30, 2017
Applicant:

Respivert Limited, Buckinghamshire, GB;

Inventors:

John King-Underwood, Pendock, GB;

Kazuhiro Ito, Wallington, GB;

Peter John Murray, Cheltenham, GB;

George Hardy, Robertsbridge, GB;

Frederick Arthur Brookfield, Benson, GB;

Christopher John Brown, Abingdon, GB;

Assignee:

Respivert Ltd., Buckinghamshire, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/90 (2006.01); A61K 31/519 (2006.01); A61K 9/14 (2006.01); A61K 9/00 (2006.01); A61K 47/26 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 9/0075 (2013.01); A61K 9/14 (2013.01); A61K 47/26 (2013.01);
Abstract

The present invention relates to the compound of formula (I) and to compositions comprising the same and to the use of the compound and to compositions of the compound in treatment, for example in the treatment of inflammatory diseases, in particular respiratory inflammatory disease. The invention also extends to methods of making the said compound.


Find Patent Forward Citations

Quick Actions:

King-Underwood, John. (2018). Quinazolin-4 (3h)-one derivatives used as p13 kinase inhibitors (U.S. Patent No. 10028959). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10028959

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…